{
    "code": "02025401",
    "time": "2015-06-25 19:02:40",
    "許可證字號": "衛署藥輸字第025401號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "105\/09\/28",
    "發證日期": "100\/09\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202540109",
    "中文品名": "普癌汰 乾粉靜脈注射劑",
    "英文品名": "Innomustine Injection",
    "適應症": "1.Binet分類stage B及C之慢性淋巴球白血病(chronic lymphocytic leukemia,CLL)。2.曾接受至少一種化療之和緩性非何杰金氏淋巴瘤，六個月內曾以rituximab治療失敗之單一治療。",
    "劑型": "270注射劑",
    "包裝": "每盒100支以下玻璃瓶裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "BENDAMUSTINE HYDROCHLORIDE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "6201119642  因華生技製藥股份有限公司",
    "申請商地址": "台北市內湖區瑞光路478巷20號9樓、22號9樓",
    "主製造廠": {
        "製造廠名稱": "F050040000  CENEXI-LABORATOIRES THISSEN S.A.",
        "製造廠廠址": "RUE DE LA PAPYREE 2-6 1420 BRAINE-L'ALLEUD BELGIUM",
        "製造廠公司地址": "",
        "製造廠國別": "BELGIUM",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004002510",
            "成分名稱": "BENDAMUSTINE HYDROCHLORIDE",
            "含量描述": "(corresponding to bendamustine 22.7 mg)",
            "含量": "25.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1004002510",
            "成分名稱": "BENDAMUSTINE HYDROCHLORIDE",
            "含量描述": "(corresponding to bendamustine 90.8mg)",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020254010004___20111019.JPG 020254010003___20111019.JPG 020254010002___20111019.JPG 020254010001___20111019.JPG",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025401&Seq=004&Type=9"
        },
        {
            "title": "外盒 020254010008___20111019.jpg 020254010007___20111019.jpg 020254010006___20111019.JPG 020254010005___20111019.JPG",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025401&Seq=004&Type=8"
        }
    ]
}